Excess mortality and hospitalizations associated with seasonal influenza in patients with heart failure

  • Daniel Modin*
  • , Brian Claggett
  • , Niklas Dyrby Johansen
  • , Scott D Solomon
  • , Ramona Trebbien
  • , Thyra Grove Krause
  • , Jens-Ulrik Stæhr Jensen
  • , Mikkel Porsborg Andersen
  • , Gunnar Gislason
  • , Tor Biering-Sørensen
  • *Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftArtikelForskningpeer review

Abstract

BACKGROUND: Influenza virus may cause severe infection in patients with heart failure. It is known that influenza infection is associated with increased morbidity and mortality in patients with heart failure. However, less is known about the excess burden of morbidity and mortality caused by influenza infection in patients with heart failure at a population level.

OBJECTIVES: The purpose of this study was to estimate the excess burden of morbidity and mortality as determined by annual excess number of deaths and hospitalizations associated with influenza infection in patients with heart failure in Denmark.

METHODS: We collected nationwide data on weekly number of deaths and hospitalizations among patients with heart failure in Denmark and weekly estimates of influenza circulation as determined by the proportion of positive influenza samples analyzed at all Danish Hospitals. These data were correlated in a time series linear regression model, and this model was used to estimate the annual excess number of deaths and hospitalizations attributable to influenza circulation among patients with heart failure in Denmark. The model also included data on weekly mean temperature and restricted cubic spline terms to account for seasonality and trends over time.

RESULTS: Data were available from 2010 to 2018 encompassing 8 influenza seasons with an annual mean of 25,180 samples tested for influenza at Danish hospitals. Among an annual mean of 70,570 patients with heart failure, our model estimated that influenza activity was associated with an annual excess of 250 all-cause deaths (95% CI: 144-489 deaths) corresponding to 2.6% of all all-cause deaths (95% CI: 1.5%-5.1%) in patients with heart failure. Similarly, influenza activity was associated with an annual excess of 115 cardiovascular deaths (95% CI: 62-244 deaths) corresponding to 2.9% of all cardiovascular deaths (95% CI: 1.5%-6.1%). Influenza activity was also associated with an annual excess of 251 hospitalizations for pneumonia or influenza (95% CI: 107-533 hospitalizations) corresponding to 5.0% of all hospitalizations for pneumonia or influenza.

CONCLUSIONS: Our results indicate that influenza activity likely causes substantial morbidity and mortality among patients with heart failure. Notably, our study suggests that approximately 2.6% of all deaths and 5.0% of all hospitalizations with influenza or pneumonia may be attributed to influenza in patients with heart failure.

OriginalsprogEngelsk
Sider (fra-til)2460-2467
Antal sider8
TidsskriftJournal of the American College of Cardiology
Vol/bind84
Udgave nummer25
Tidlig onlinedato31 aug. 2024
DOI
StatusUdgivet - 17 dec. 2024

Finansiering

Bevillingsgivere
Alexion Pharmaceuticals, Inc.
Alnylam Pharmaceuticals
Applied Therapeutics
AstraZeneca
Bellerophon Therapeutics
Bayer España
Bristol-Myers Squibb
Boston Scientific Corporation
Cytokinetics, Inc.
National Institutes of Health
Edgewise Therapeutics
Novartis
BridgeBio Pharma Inc.
Novo Nordisk Foundation
Gossamer Bio
Respicardia Inc.
GlaxoSmithKline
Sanofi
Ionis Pharmaceuticals
Tenaya Therapeutics
Eli Lilly
TheracosBio
Us2.ai
GlaxoSmithKline
Pfizer
GE Healthcare
IQVIA Inc.
PAREXEL International
Amgen Incorporated
CSL Seqirus

    Fingeraftryk

    Udforsk hvilke forskningsemner 'Excess mortality and hospitalizations associated with seasonal influenza in patients with heart failure' indeholder.

    Citationsformater